Lv37
240 积分 2024-01-11 加入
Efficacy of Ustekinumab for Inducing Endoscopic Healing in Patients With Crohn’s Disease
1天前
待确认
Adalimumab Induces and Maintains Clinical Remission in Patients With Moderate-to-Severe Ulcerative Colitis
1天前
已完结
Ozanimod induction therapy for patients with moderate to severe Crohn's disease: a single-arm, phase 2, prospective observer-blinded endpoint study
2天前
已完结
Efficacy and safety of 48 weeks of guselkumab for patients with Crohn's disease: maintenance results from the phase 2, randomised, double-blind GALAXI-1 trial
2天前
已完结
Development and validation of a new, simplified endoscopic activity score for Crohn's disease: the SES-CD
2天前
已完结
RIPK2 inhibitors for disease therapy: Current status and perspectives
2天前
已完结
Low-dose MTX combined with low-dose methylprednisolone as a first-line therapy for the treatment of acute GVHD: safety and feasibility
1个月前
已完结
Haematopoietic stem-cell transplantation in China in the era of targeted therapies: current advances, challenges, and future directions
1个月前
已完结
Chronic graft-versus-host disease. Part II: Disease activity grading and therapeutic management
1个月前
已完结
Chronic GVHD: review advances in prevention, novel endpoints, and targeted strategies
1个月前
已关闭
皖公网安备34019202002308
